Abstract
Complementary cell lines have become an accepted tool for the functional analysis of viral genes (1,2) and proteins, as well as an essential component in strategies for the construction of mutant viruses. More recent applications include the propagation of replication-defective virus products with potential as viral vaccines (3,4) or as vehicles for gene therapy (5,6). The perceived requirements for such systems are low recombination frequencies between complementing cell and recombinant virus, stable expression of the complementing protein within the cell, and efficient complementation. The standard techniques of eukaryotic cell transfection and clonal selection are routinely employed in the generation of complementary cell lines, and are described briefly in this chapter. Perhaps a more novel introduction to this field is the possibility of using transgenic technology. Transgenic animals have the potential to provide both an in vivo model of complementation (7) and a comprehensive library of novel complementing cell types, particularly cell types resistant to traditional transfection protocols.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gao, M., Colonno, R. J., et.al (1994) The protease of Herpes Simplex Virus Type 1 is essential for functional capsid formation and viral growth. J Virol 68, 6 3702–3712
Johnson, P. A., Best, M. G, Friedmann, T., and Parris, D. S. (1991) Isolation of a Herpes Simplex Virus Type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype J Virol 65, 2 700–710.
Nguyen, L. H., Knipe, D M., and Finberg, R. W (1992) Replication-defective mutants of Herpes Simplex Virus (HSV) induce cellular immunity and protect against lethal HSV infection J. Virol 66, 12 7067–7072
Farrell, H. E., Mclean, C. S, Harley, C, Estathiou, S, Inglis, S., and Minson, A C (1994) Vaccine potential of a Herpes Simplex Virus Type 1 mutant with an essential glycoprotein deleted J. Virol 68, 2 927–932
Lokensgard, J R., Bloom, D. C., Dobson, A T., and Feldman, L T. (1994) Long term promoter activity during Herpes Simplex Virus latency. J Virol 68, 11 7148–7158
Geller, A. L, Keyomarsi, K., Bryan, J, and Pardee, A.B (1990) An efficient deletion mutant packaging system for defective Herpes Simplex Virus vectors, potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA 87, 22 8950–8954
Smith, C A and DeLuca, N A (1992)Transdominant inhibition of Herpes Simplex Virus growth in transgenic mice. Virology 191, 581–588.
Murray, E J., ed. (1991) Gene transfer and expression protocols, Methods in Molecular Biology (Walker, J. M., ed.), Humana, Totowa, NJ
Extraction, purification and analysis of mRNA from eucaryotic cells, in Molecular Cloning. A Laboratory Manual, vol. 1, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 7.3–7 30.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Entwisle, C. (1998). Construction and Use of Cell Lines Expressing HSV Genes. In: Brown, S.M., MacLean, A.R. (eds) Herpes Simplex Virus Protocols. Methods in Molecular Medicine, vol 10. Humana Press. https://doi.org/10.1385/0-89603-347-3:89
Download citation
DOI: https://doi.org/10.1385/0-89603-347-3:89
Publisher Name: Humana Press
Print ISBN: 978-0-89603-347-4
Online ISBN: 978-1-59259-594-5
eBook Packages: Springer Protocols